Cargando…

Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway

Verteporfin, a FDA approved second-generation photosensitizer, has been demonstrated to have anticancer activity in various tumors, but not including papillary thyroid cancer (PTC). In current pre-clinical pilot study, we investigate the effect of verteporfin on proliferation, apoptosis, cell cycle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Tian, Wei, Wen-Jun, Wen, Duo, Hu, Jia-Qian, Wang, Yu, Ma, Ben, Cao, Yi-Min, Xiang, Jun, Guan, Qing, Chen, Jia-Ying, Sun, Guo-Hua, Zhu, Yong-Xue, Li, Duan-Shu, Ji, Qing-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929076/ https://www.ncbi.nlm.nih.gov/pubmed/29721041 http://dx.doi.org/10.7150/jca.21915

Ejemplares similares

Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway
por: Liao, Tian, et al.
Publicado: (2016)

PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer
por: Liu, Wan-Lin, et al.
Publicado: (2021)

IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro
por: Hu, Jia-Qian, et al.
Publicado: (2020)

Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma
por: Lu, Zhong-Wu, et al.
Publicado: (2020)

IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis
por: Han, Li-Tao, et al.
Publicado: (2019)

IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis
por: Lu, Zhong-Wu, et al.
Publicado: (2020)

Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer
por: Zhang, Hui-Min, et al.
Publicado: (2022)

Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β‐catenin signaling and sensitizes cancer cells to FH535 therapy
por: Wen, Duo, et al.
Publicado: (2018)

The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma
por: Hu, Jia‐Qian, et al.
Publicado: (2019)

SNHG9, a Papillary Thyroid Cancer Cell Exosome-Enriched lncRNA, Inhibits Cell Autophagy and Promotes Cell Apoptosis of Normal Thyroid Epithelial Cell Nthy-ori-3 Through YBOX3/P21 Pathway
por: Wen, Duo, et al.
Publicado: (2021)

In vitro effects of verteporfin on ocular cells
por: Ammar, David A., et al.
Publicado: (2013)

Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation
por: Chen, Min, et al.
Publicado: (2017)

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
por: Liao, Tian, et al.
Publicado: (2016)

The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma
por: Wang, Nanpeng, et al.
Publicado: (2018)

Number of tumor foci predicts prognosis in papillary thyroid cancer
por: Qu, Ning, et al.
Publicado: (2014)

Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2017)

Association of the miR-149 Rs2292832 Polymorphism with Papillary Thyroid Cancer Risk and Clinicopathologic Characteristics in a Chinese Population
por: Wei, Wen-Jun, et al.
Publicado: (2014)

CRLF1–MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis
por: Yu, Shi-Tong, et al.
Publicado: (2020)

Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation
por: Wei, Changran, et al.
Publicado: (2020)

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2016)

Differential gene expression induced by Verteporfin in endometrial cancer cells
por: Bang, Lisa Gahyun, et al.
Publicado: (2019)

Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function
por: Xiong, Jixian, et al.
Publicado: (2019)

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
por: Lee, Jun Mok, et al.
Publicado: (2007)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
por: Golino, Jihye L., et al.
Publicado: (2023)

LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma
por: Xiang, Jingjing, et al.
Publicado: (2020)

Corrigendum: Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2017)

LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway
por: Guan, Yue, et al.
Publicado: (2021)

A rare laryngeal tumor in a patient with thyroid papillary cancer: granular cell tumor()
por: Cheng, Sheng-Yao, et al.
Publicado: (2016)

CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27
por: Li, Hai, et al.
Publicado: (2018)

Xanthoxyletin Inhibits Proliferation of Human Oral Squamous Carcinoma Cells and Induces Apoptosis, Autophagy, and Cell Cycle Arrest by Modulation of the MEK/ERK Signaling Pathway
por: Wen, Qingquan, et al.
Publicado: (2019)

Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells
por: Dasari, Venkata Ramesh, et al.
Publicado: (2020)

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
por: Jin, Jun-Qing, et al.
Publicado: (2021)

miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10
por: Liu, Fangzhou, et al.
Publicado: (2018)

Retracted: Xanthoxyletin Inhibits Proliferation of Human Oral Squamous Carcinoma Cells and Induces Apoptosis, Autophagy, and Cell Cycle Arrest by Modulation of the MEK/ERK Signaling Pathway
por: Wen, Qingquan, et al.
Publicado: (2021)

MicroRNA-3690 promotes cell proliferation and cell cycle progression by altering DKK3 expression in human thyroid cancer
por: Shen, Fei, et al.
Publicado: (2020)

Nomogram prediction for cervical lymph node metastasis in multifocal papillary thyroid microcarcinoma
por: Li, Wen-Hui, et al.
Publicado: (2023)

Preliminary screening and analysis of metastasis-related lncRNA and co-expressed papillary thyroid carcinoma mRNA
por: Ge, Ming-Hua, et al.
Publicado: (2018)

Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer
por: Zeng, Feng, et al.
Publicado: (2018)

Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells
por: Hanly, Elyse K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6qn4t5ptb6j7nsbivacj842hnc